Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2012 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

Components of
DT Vaccine

Excipients Table
Allergens Table
Components Table

 

Indication

To prevent infection with Corynebacterium diphtheriae and Clostridium tetani.

Proprietary Name

DT (generic)

Manufacturer

sanofi pasteur

Viability

Inactivated

Microorganism

Corynebacterium diphtheriae and Clostricium tetani

Ages up to 7 years 

Dose

0.5 mL

Route

Intramuscular

Dose form

Suspension

Appearance

Turbid liquid, white, slightly gray

Concentration (per 0.5 mL)

Diphtheria, 6.7 Lf U

Tetanus, 5 LF U

Preservatives

Single dose - Thimerosal, 0.3 mcg

Adjuvant

Aluminum potassium sulfate ( 0.25 mg aluminum)

Excipients

Formaldehyde (residual-free), ≤0.02%

Variously formulated with glycine, sodium phosphate, sodium acetate, hydrochloric acid or sodium hydroxide

Allergens

None

Media

Modified Mueller and Miller

Pepton-based medium containing bovine extract

Packaging

Single-dose (0.5 mL) vials

Routine storage

2 to 8° C (36-46° F)

Do Not Freeze

PI Last updated December 2005

Table Information last updated Oct 2012

 

This page was last updated on October 23, 2012

© 2012 Institute for Vaccine Safety